i2Dx has a total of 35 patents globally, out of which 13 have been granted. Of these 35 patents, more than 57% patents are active. United States of America is where i2Dx has filed the maximum number of patents, followed by Japan and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of i2Dx.
i2Dx, founded in 2012 and based in San Francisco, is a private health technology company developing a cloud-based diagnostic platform for neurological disorders. Their system provides quantitative digital assessments of biomarkers indicative of brain health, aiming to create personalized, longitudinal brain records for both healthy individuals and patients. The company has secured early-stage venture capital funding from investors like Biomark Capital and EDVentures Holdings
Do read about some of the most popular patents of i2Dx which have been covered by us in this article and also you can find i2Dx patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over i2Dx patent portfolio.
How many patents does i2Dx have?
i2Dx has a total of 35 patents globally. These patents belong to 3 unique patent families. Out of 35 patents, 20 patents are active.
How Many Patents did i2Dx File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | i2Dx Applications Filed | i2Dx Patents Granted |
| 2025 | – | 1 |
| 2024 | 1 | 2 |
| 2023 | 1 | 1 |
| 2022 | – | 2 |
| 2021 | 8 | 3 |
| 2020 | 1 | 1 |
| 2019 | 8 | – |
| 2018 | 1 | 1 |
| 2017 | 2 | 2 |
| 2016 | 2 | – |
| 2014 | 10 | – |
| 2013 | 1 | – |
How many i2Dx patents are Alive/Dead?
Worldwide Patents
How Many Patents did i2Dx File in Different Countries?
Countries in which i2Dx Filed Patents
| Country | Patents |
| United States of America | 10 |
| Japan | 6 |
| Europe (EPO) | 4 |
| Australia | 4 |
| China | 2 |
| Canada | 1 |
| Germany | 1 |
| Korea (South) | 1 |
| Brazil | 1 |
Where are Research Centres of i2Dx Patents Located?
The Research Centre for all the i2Dx patents is the United States of America.
Best Patents of i2Dx
US10660522B2 is the most popular patent in the i2Dx portfolio. It has received 29 citations so far from companies like Abbott Laboratories and Emed Labs Llc.
Below is the list of most cited patents of i2Dx:
| Publication Number | Citation Count |
| US10660522B2 | 29 |
| US9782075B2 | 20 |
| CN105612551A | 2 |
| US11076798B2 | 1 |
| KR101818022B1 | 1 |
What Percentage of i2Dx US Patent Applications were Granted?
i2Dx (Excluding its subsidiaries) has filed 10 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 has been granted leading to a grant rate of 100%.
Below are the key stats of i2Dx patent prosecution at the USPTO.
Which Law Firms are Managing US Patents for i2Dx?
| Law Firm | Total Applications | Success Rate |
| Maschoff Brennan | 10 | 100s% |
List of i2Dx Patents
| i2Dx Patents | Title |
| US12312639B2 | Alzheimer’S Disease Personalized Medicine |
| JP2025032200A | Intelligent Systems And Methods For Therapeutic Target Identification |
| EP2973363B1 | Electronic Delivery Of Information In Personalized Medicine |
| DE602014089260T2 | Electronic Delivery Of Information In Personalized Medicine |
| US20240024417A1 | Therapeutic Modulation Of Alcam/Cd166 |
| EP4225947A4 | Therapeutic Modulation Of Alcam/Cd166 |
| US11723582B2 | Non-Invasive And Non-Contact Measurement In Early Therapeutic Intervention |
| JP2023546836A | Therapeutic Modulation Of Alcam/Cd166 |
| JP2023103221A | Intelligent System And Methods For Therapeutic Target Identification |
| US11419497B2 | Electronic Delivery Of Information In Personalized Medicine |
| JP7112660B2 | Electronic Distribution Of Information In Individualized Medicine |
| US20220022749A1 | Alzheimer’S Disease Personalized Medicine |
| US20220005548A1 | Intelligent System And Methods For Therapeutic Target Identification |
| EP3874455A4 | Intelligent System And Methods For Therapeutic Target Identification |
| WO2022081525A1 | Therapeutic Modulation Of Alcam/Cd166 |
| JP2022506192A | Intelligent Systems And Methods For Therapeutic Target Identification |
| US11089959B2 | Electronic Delivery Of Information In Personalized Medicine |
| US11076798B2 | System And Method For Non-Invasive And Non-Contact Measurement In Early Therapeutic Intervention |
| CA2907207C | Electronic Delivery Of Information In Personalized Medicine |
| EP3764902A4 | Electronic Delivery Of Information In Personalized Medicine |
| AU2021203400A1 | Electronic Delivery Of Information In Personalized Medicine |
| US10660522B2 | Electronic Delivery Of Information In Personalized Medicine |
| CN111540474A | Electronic Delivery Of Information In Personalized Medicine |
| WO2020092753A1 | Intelligent System And Methods For Therapeutic Target Identification |
| WO2019178167A1 | Electronic Delivery Of Information In Personalized Medicine |
| AU2019202082A1 | Electronic Delivery Of Information In Personalized Medicine |
| KR101818022B1 | Electronic Delivery Of Information In Personalized Medicine |
| US9782075B2 | Electronic Delivery Of Information In Personalized Medicine |
| JP6253166B2 | Electronic Distribution Of Information In Personalized Medicine |
| WO2017062994A1 | System And Method For Non-Invasive And Non-Contact Measurement In Early Therapeutic Intervention |
| BR112015023323A2 | Systems For The Electronic Supply Of Information And For Automated And Advanced Data Analytical And Health Care Delivery Method |
| AU2017204178A1 | Electronic Delivery Of Information In Personalized Medicine |
| CN105612551A | Electronic Delivery Of Information In Personalized Medicine |
| AU2014227595A1 | Electronic Delivery Of Information In Personalized Medicine |
| WO2014144404A1 | Electronic Delivery Of Information In Personalized Medicine |
What are i2Dx key innovation segments?
What Technologies are Covered by i2Dx?
The chart below distributes patents filed by i2Dx in different countries on the basis of the technology protected in patents. It also represents the markets where i2Dx thinks it’s important to protect particular technological inventions.
R&D Focus: How has i2Dx search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by i2Dx?
